For the quarter ending 2026-03-31, UHS had -$18,769K decrease in cash & cash equivalents over the period. $184,471K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income | 358,678 | 447,837 | 379,105 | 362,612 |
| Depreciation & amortization | 155,426 | 163,334 | 155,060 | 152,004 |
| Stock-based compensation expense | 22,504 | 25,102 | 24,879 | 24,112 |
| Unrealized gain on non-marketable securities | - | 93,291 | - | - |
| Gain on sales of assets and businesses | 5,046 | -5,135 | 0 | -2,833 |
| Costs related to extinguishment of debt | - | 0 | - | - |
| Accounts receivable | 123,862 | 23,775 | 201,574 | -125,738 |
| Accrued interest | -10,992 | 11,105 | -11,584 | 15,618 |
| Accrued and deferred income taxes | -104,772 | -17,846 | -16,626 | 144,554 |
| Other working capital accounts | 122,911 | -78,774 | 4,909 | -68,148 |
| Other assets and deferred charges | 12,257 | -1,030 | 7,225 | 21,915 |
| Other, net | -221 | 586 | 2,971 | 12,332 |
| Accrued insurance expense, net of commercial premiums paid | 62,568 | 59,717 | 82,358 | 47,362 |
| Payments made in settlement of self-insurance claims, net of commercial insurance reimbursements | 49,015 | 96,497 | 78,197 | 84,781 |
| Deferred grant revenue | - | 0 | - | - |
| Net cash provided by operating activities | 401,628 | 574,693 | 380,678 | 548,978 |
| Property and equipment additions | 217,157 | 281,220 | 228,892 | 266,014 |
| Proceeds received from sales of assets and businesses | 14,304 | 12,883 | 0 | 2,980 |
| Acquisition of businesses and property | 4,857 | 32 | 39,458 | 0 |
| Inflows (outflows) from foreign exchange contracts that hedge our net u.k. investment | -14,716 | 2,862 | -17,051 | 42,707 |
| Costs incurred for purchase and development of enterprise resource planning application | 4,613 | 6,019 | 18,676 | - |
| Proceeds received from sale of marketable equity securities | - | 63,073 | - | - |
| Investments in non-marketable securities | - | 9,831 | - | - |
| Decrease (increase) in capital reserves of commercial insurance subsidiary | -28 | -42 | -562 | 198 |
| Net cash used in investing activities | -197,579 | -223,966 | -269,413 | -305,939 |
| Repayments of long-term debt | 44,731 | 15,713 | 9,243 | 9,435 |
| Additional borrowings | 40 | 76,550 | 114,385 | -57,853 |
| Financing costs | - | 0 | 382 | - |
| Repurchase of common shares | 163,849 | 352,010 | 237,399 | 155,157 |
| Dividends paid | 12,974 | 12,365 | 12,468 | 12,900 |
| Issuance of common stock | 3,782 | 4,610 | 3,982 | 4,479 |
| Profit distributions to noncontrolling interests | 7,912 | 1,325 | 788 | 3,709 |
| Purchase of ownership interests by minority members, net | 3,750 | 4,118 | 7,392 | 6,924 |
| Net cash used in financing activities | -221,894 | -296,135 | -134,521 | -227,651 |
| Effect of exchange rate changes on cash and cash equivalents | -924 | 127 | -1,541 | 2,286 |
| Decrease in cash, cash equivalents and restricted cash | -18,769 | 54,719 | -24,797 | 17,674 |
| Cash, cash equivalents and restricted cash, beginning of period | 271,322 | 216,603 | 241,400 | 223,726 |
| Cash, cash equivalents and restricted cash, end of period | 252,553 | 271,322 | 216,603 | 241,400 |
UNIVERSAL HEALTH SERVICES INC (UHS)
UNIVERSAL HEALTH SERVICES INC (UHS)